Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein.
暂无分享,去创建一个
M. Willingham | K. Bhalla | A. Frankel | R. Kreitman | P. Hall | A. Frankel | C. Burbage | J. Veselý | Joseph Vesely
[1] J. Perentesis,et al. Induction of apoptosis in multidrug-resistant and radiation-resistant acute myeloid leukemia cells by a recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] K. Bhalla,et al. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[3] W. Wilmanns,et al. Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. , 1996, Leukemia.
[4] M. Willingham,et al. Interleukin 2 (IL-2) receptor expression and sensitivity to diphteria fusion toxin DAB389IL-2 in cultured hematopoietic cells. , 1996, Cancer research.
[5] K. Tew,et al. Glutathione and related enzymes in multidrug resistance. , 1996, European journal of cancer.
[6] A. List,et al. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. , 1996, Leukemia.
[7] M. Cohen,et al. Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface. , 1996, Anticancer research.
[8] K. Arai,et al. Differential expression of granulocyte-macrophage colony-stimulating factor and IL-3 receptor subunits on human CD34+ cells and leukemic cell lines. , 1995, The Journal of allergy and clinical immunology.
[9] P. Bamborough,et al. Molecular modeling of the GM‐CSF and IL‐3 receptor complexes , 1995, Protein science : a publication of the Protein Society.
[10] W. Balch,et al. Ricin Cytotoxicity Is Sensitive to Recycling between the Endoplasmic Reticulum and the Golgi Complex (*) , 1995, The Journal of Biological Chemistry.
[11] K. Klimpel,et al. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases , 1995, Infection and immunity.
[12] P. Johnson,et al. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. , 1994, Oncogene.
[13] S. Proctor,et al. The relationship between bcl‐2 expression and response to chemotherapy in acute leukaemia , 1994, British journal of haematology.
[14] A. Dunn,et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] David L. Vaux,et al. An evolutionary perspective on apoptosis , 1994, Cell.
[16] A. Miyajima,et al. Critical cytoplasmic domains of the common beta subunit of the human GM‐CSF, IL‐3 and IL‐5 receptors for growth signal transduction and tyrosine phosphorylation. , 1992, The EMBO journal.
[17] M. Hallek,et al. Interferon-gamma increases the expression of the gene encoding the beta subunit of the granulocyte-macrophage colony-stimulating factor receptor. , 1992, Blood.
[18] D. Russell,et al. Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor , 1992, Cell.
[19] Katherine A. Kantardjieff,et al. The crystal structure of diphtheria toxin , 1992, Nature.
[20] C. Bugg,et al. Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor. , 1992, Journal of molecular biology.
[21] M. Belvin,et al. Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells. , 1991, Blood.
[22] O. Haas,et al. MDR1 gene expression and treatment outcome in acute myeloid leukemia. , 1991, Journal of the National Cancer Institute.
[23] S. Cannistra,et al. Identification of functionally distinct domains of human granulocyte- macrophage colony-stimulating factor using monoclonal antibodies , 1991 .
[24] T. Waldmann,et al. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Haman,et al. IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferation. , 1990, Leukemia.
[26] K. Miyazono,et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin , 1989, Journal of cellular physiology.
[27] A. Gazdar,et al. Nonhematopoietic tumor cells express functional GM-CSF receptors , 1989 .
[28] P. Casellas,et al. An anti‐CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albumin‐monensin , 1989, International journal of cancer.
[29] K. Kaushansky,et al. Hematopoietic activity of granulocyte/macrophage colony-stimulating factor is dependent upon two distinct regions of the molecule: functional analysis based upon the activities of interspecies hybrid growth factors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[30] G. Demetri,et al. In vitro expression of colony-stimulating factor genes by human acute myeloblastic leukemia cells. , 1988, Experimental hematology.
[31] M. Minden,et al. Binding of iodinated recombinant human GM-CSF to the blast cells of acute myeloblastic leukemia. , 1988, Leukemia.
[32] E. Vellenga,et al. Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. , 1987, Leukemia.
[33] P. Nowell,et al. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines , 1987 .
[34] T. Papayannopoulou,et al. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. , 1982, Science.
[35] K. Tada,et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. , 1982, Cancer research.
[36] C. Lozzio,et al. A Multipotential Leukemia Cell Line (K-562) of Human Origin 1 , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[37] J. Howard,et al. ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products. , 1980, The Journal of biological chemistry.
[38] H. Koeffler,et al. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. , 1978, Science.
[39] K. Nilsson,et al. Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) , 1976, International journal of cancer.
[40] S Farber,et al. Morphologic variations in human leukemic lymphoblasts (CCRF‐CEM cells) after long‐term culture and exposure to chemotherapeutic agents: A study with the electron microscope , 1966, Cancer.
[41] H. Eagle,et al. Propagation in a Fluid Medium of a Human Epidermoid Carcinoma, Strain KB , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[42] P. Wingo,et al. Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.
[43] J. Rasko,et al. Cytokine receptor expression on hematopoietic stem and progenitor cells. , 1997, Blood.
[44] J. Reed,et al. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein. , 1996, Leukemia.
[45] D. Scheinberg,et al. Antileukemic activity of recombinant humanized M195-gelonin immunotoxin in nude mice. , 1996, Leukemia.
[46] B. G. Sanders,et al. RRR‐α‐tocopheryl succinate induces apoptosis in avian retrovirus‐transformed lymphoid cells , 1996 .
[47] K. Cowan,et al. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. , 1995, Blood.
[48] T. Strom,et al. Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules. , 1994, Advances in nephrology from the Necker Hospital.
[49] R. Salgia,et al. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1. , 1994, Experimental hematology.
[50] G. Demetri,et al. The biology of GM-CSF: regulation of production and interaction with its receptor. , 1990, International journal of cell cloning.
[51] E. Freireich,et al. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. , 1988, Blood.
[52] J. Murphy. The diphtheria toxin structural gene. , 1985, Current topics in microbiology and immunology.